Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Instituto de Salud Global - Institute For Global Health Barcelona (ISGlobal); University of Barcelona; McGill University = Université McGill Montréal, Canada; Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD); Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM); Linköping University (LIU); Alma Mater Studiorum Università di Bologna = University of Bologna (UNIBO); Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria "San Martino" (IRCCS AOU San Martino); University Medical Centre Ljubljana Ljubljana, Slovenia (UMCL); Sorbonne Université - Faculté de Médecine (SU FM); Sorbonne Université (SU); CHU Pitié-Salpêtrière AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU); Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd); Liver Unit, Clínica Universitaria, CIBER-EHD; Hospital Universitario Virgen del Rocío Sevilla; Charité - UniversitätsMedizin = Charité - University Hospital Berlin; University of Haifa Haifa; Universidade de Lisboa = University of Lisbon = Université de Lisbonne (ULISBOA); Newcastle University Newcastle
    • بيانات النشر:
      HAL CCSD
      Elsevier
    • الموضوع:
      2021
    • Collection:
      Inserm: HAL (Institut national de la santé et de la recherche médicale)
    • نبذة مختصرة :
      International audience ; Background & aims: Non-alcoholic fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly prevalent emerging condition that can be optimally managed through a multidisciplinary patient-centred approach. National preparedness to address NAFLD is essential to ensure that health systems can deliver effective care. We present a NAFLD Preparedness Index for Europe.Methods: In June 2019, data were extracted by expert groups from 29 countries to complete a 41-item questionnaire about NAFLD. Questions were classified into 4 categories: policies/civil society (9 questions), guidelines (16 questions), epidemiology (4 questions), and care management (12 questions). Based on the responses, national preparedness for each indicator was classified into low, middle, or high-levels. We then applied a multiple correspondence analysis to obtain a standardised preparedness score for each country ranging from 0 to 100.Results: The analysis estimated a summary factor that explained 71.3% of the variation in the dataset. No countries were found to have yet attained a high-level of preparedness. Currently, the UK (75.5) scored best, although falling within the mid-level preparedness band, followed by Spain (56.2), and Denmark (43.4), whereas Luxembourg and Ireland were the lowest scoring countries with a score of 4.9. Only Spain scored highly in the epidemiology indicator category, whereas the UK was the only country that scored highly for care management.Conclusions: The NAFLD Preparedness Index indicates substantial variation between countries' readiness to address NAFLD. Notably, even those countries that score relatively highly exhibit deficiencies in key domains, suggesting that structural changes are needed to optimise NAFLD management and ensure effective public health approaches are in place.Lay summary: Non-alcoholic fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly ...
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/33733078; hal-03174867; https://hal.sorbonne-universite.fr/hal-03174867; https://hal.sorbonne-universite.fr/hal-03174867/document; https://hal.sorbonne-universite.fr/hal-03174867/file/1-s2.0-S2589555921000100-main.pdf; PUBMED: 33733078; PUBMEDCENTRAL: PMC7937562
    • الرقم المعرف:
      10.1016/j.jhepr.2021.100234
    • الدخول الالكتروني :
      https://hal.sorbonne-universite.fr/hal-03174867
      https://hal.sorbonne-universite.fr/hal-03174867/document
      https://hal.sorbonne-universite.fr/hal-03174867/file/1-s2.0-S2589555921000100-main.pdf
      https://doi.org/10.1016/j.jhepr.2021.100234
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.9603123D